Amneal Pharmaceuticals

Amneal Pharmaceuticals

World Rank (Aug-2026)
3076
Market Cap (Aug-2026)
6.322 Billion USD
World Rank (Jan-05-2024)
6,045
Market Cap (Jan-05-2024)
1.809 Billion USD
World Rank (Jul-30-2023)
8,910
Market Cap (Jul-30-2023)
0.965 Billion USD
World Rank (Jan-07-2022)
11,500
Market Cap (Jan-07-2022)
0.692 Billion USD
World Rank (Jan-01-2021)
9,724
Market Cap (Jan-01-2021)
0.675 Billion USD
Headquarters Country
USA
Top Healthcare Companies in USA
Top Pharmaceutical Companies in USA
Nasdaq / NYSE Code
AMRX
Employee Count
7,000
Employee Count as of Date
As on 2021
Headquarters City/State
New Jersey
World Region
Americas
World Subregion
Northern America
Annual Revenue in USD
3,019 Million USD
Annual Operating Income in USD
394 Million USD
Annual Net Income in USD
72 Million USD
Annual Results for Period Ending
For year ending December-2025
Total Assets in USD
3,678 Million USD
Total Liabilities in USD
3,750 Million USD
Total Equity in USD
-71 Million USD
Balance Sheet for Period Ending
As of December-2025
Business Sector
Healthcare
Pharmaceutical
HealthCare Products
Company Website
AMNEAL PHARMACEUTICALS INC
Yahoo
Yahoo @ NYSE
Company Profile
Amneal Pharmaceuticals is an Integrated Specialty Pharmaceutical company. It is powered by a robust U.S. generics business and a growing branded business and focused on delivering outcomes that meet important medical needs, make quality medicines more accessible and more affordable and provide solutions for tomorrows health challenges. The headquarters is in USA.
IPO Year
2018
Stock Exchange
NYSE
Frankfurt
Nasdaq Sector
Health Care
Nasdaq Industry
Biotechnology: Pharmaceutical Preparations

Share